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Research Article 
The Impact of an Epilepsy Self-Management Program on Healthcare 
Utilization and Related Costs 
—Emily Dwyer (Editor: Rosie Donegan, Jennifer Lee)  
A chronic medical condition such as epilepsy requires a lifetime of monitoring and management by a 
medical team and the patient. The treatment is often multidisciplinary and can include medication, 
surgery, education, and self-management. This last approach focuses on teaching patients to monitor 
and respond to symptoms on their own while utilizing their healthcare team for guidance and support. 
For ten weeks during the summer of 2015, I participated as an intern in evaluating the cost 
effectiveness of Home Based Self-Management and Cognitive Training Changes Lives 
(HOBSCOTCH), an epilepsy self-management program developed at the Dartmouth-Hitchcock 
Epilepsy Center. The center is staffed by nurse practitioners, physicians, and nurses who specialize in 
epilepsy treatment, and who also conduct research on epilepsy and its management. HOBSCOTCH is 
an experimental program and is not offered as a part of general epilepsy care at this time. 
My internship was part of the IDeA 
Network for Biomedical Research 
Excellence (INBRE) Summer 
Undergraduate Research Fellowship 
(SURF) in Nursing.  This program 
receives funding from the National 
Institutes of Health with the aim of 
increasing undergraduate research 
opportunities in the state of New 
Hampshire.  As a junior nursing 
major, I applied for this summer 
program because research 
opportunities in nursing are rare for 
undergraduates. Often nursing is seen 
as a purely clinical profession, when 
in reality research is the backbone of 
all clinical skills. 
The HOBSCOTCH program ran from 
January of 2013 to June of 2014, and 
the effectiveness of the program was then evaluated. When I began my internship in June of 2015, the 
research team wanted to assess the cost effectiveness of the program. I helped accomplish this by 
focusing on how the program impacted participants’ utilization of the healthcare system. 
 
The author presented her research at the New Hampshire 
IDeA Network of Biomedical Research Excellence annual 
meeting at the Wentworth by the Sea Hotel in New Castle, 
NH, August 2015 (Photo by Jon Gilbert Fox). 
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What is Epilepsy? 
Before my internship, I did not have an extensive knowledge of epilepsy or its management, but I 
learned much more by shadowing my mentor in the epilepsy clinic and inpatient unit. Additionally, I 
was able to observe a surgery on an epilepsy patient. These clinical experiences, in combination with 
my own research on the subject, helped me to learn a lot about epilepsy and just how great of an 
impact it can have on someone’s life. 
More than four million adults in the United States have a diagnosis of epilepsy (4). This is a chronic 
condition in which an individual experiences recurring seizures (10). Cerebral neurons that ordinarily 
discharge electrical impulses to complete a specific task, fire suddenly and excessively (10). Epilepsy 
can be either primary or secondary, and the resulting seizures from both are classified as generalized 
or focal (partial).  Primary epilepsy is idiopathic, meaning it has no known cause, although there may 
be genetic components. Secondary epilepsy is the result of an underlying condition such as a brain 
tumor. The resulting seizures present differently in each person and are dependent on the location and 
type of seizure. 
A generalized seizure rapidly engages neurons in both hemispheres and is the type of seizure that 
most people have heard of. It involves the rhythmic contraction and relaxation of muscles, and the 
individual often loses consciousness. A focal, or partial, seizure involves only one hemisphere of the 
brain. The whole body is typically not involved, and there are a number of different presentations, 
such as the twitching of one limb, behavioral changes, staring, or loss of muscle tone. 
A number of treatment options exist for individuals with epilepsy, but these do not guarantee freedom 
from all symptoms. Patients and providers struggle to maintain the balance between a safe, effective 
medication dose and the numerous possible side effects. Examples of side effects are dizziness, 
sedation, weight gain, and cognitive slowing, among many others. Surgery is another treatment 
option if medication options are not successful. When an individual’s epilepsy stems from a singular, 
well-defined area of the brain, this section may be removed to help control the individual’s epilepsy. 
Depending on the location, there can be a number of physical and cognitive effects. Another option is 
the surgical placement of a vagus nerve stimulator (VNS). Similar to a cardiac pacemaker, it is placed 
in the chest and sends electrical impulses to the brain via the vagus nerve. Individuals can induce 
additional electrical impulses during the onset of a seizure. These impulses help to reduce seizure 
severity and frequency. HOBSCOTCH and Memory Impairment 
Many individuals with epilepsy report cognitive impairments, particularly regarding memory (5). As 
a result, HOBSCOTCH was designed to specifically address memory impairment in those with 
epilepsy. Multiple factors contribute to memory impairment, including both the seizures themselves 
and the form of treatment. Regardless of cause, the treatment of cognitive changes due to epilepsy is 
multidisciplinary and involves general medication management, behavior management, support, and 
memory and cognitive training (7). HOBSCOTCH specifically aims to help patients by providing this 
training and support. 
The program structure includes an initial group visit; six individual, weekly telephone sessions; and a 
final visit. Each of these takes place with a memory coach, a nurse practitioner or nurse who 
specializes in epilepsy and has received training in problem solving therapy. In this therapy, the 
coach teaches the patient how to assess external factors, such as the environment, and internal factors, 
such as feelings, that contribute to memory impairment. The memory coach can then use different 
strategies to help the patient work with these contributing factors (3). 
During the initial group visit at the medical center, patients are educated on epilepsy and how it 
affects cognitive function, with an emphasis on memory.  The patients are then introduced to the 
program, given a workbook and a day planner. In the planner, patients record seizure activity and 
write down events they need to remember. Pages in the workbook are dedicated to each week of the 
program. Here they record any memory problems they are experiencing and brainstorm ways to work 
with them. Patients are prompted to evaluate the pros and cons of each potential solution and pick the 
most appropriate one. They then put the chosen plan into action and evaluate it at the next weekly 
telephone session. During these sessions the coach teaches them new strategies to work with memory 
impairment and offers support. The program concludes with the final, in-person visit. 
Between January 2013 and June 2014, a total of fifty-seven patients participated in the 
HOBSCOTCH program. These patients all had subjective, or self-reported, memory complaints; 
were between eighteen and sixty-five years of age; had an IQ above 70; no difficulty reading or 
writing; reliable telephone access; and were on a stable medication regime (antiepileptics and 
antidepressants) for at least one month. The fifty-seven patients were randomized into one of three 
groups: those who participated in the program (the intervention group), the intervention plus 
computerized cognitive training group, and the control group. Those in the computerized cognitive 
training group participated in HOBSCOTCH and additionally used a Nintendo DS for cognitive 
training. Those in the control group did not participate in HOBSCOTCH and received care as usual. 
In the follow-up evaluative study in 2014, the primary outcome, or variable of interest, was quality of 
life. The Quality of Life in Epilepsy (QOLIE-31) questionnaire was used to measure this variable. 
One secondary outcome was objective memory, or memory that can be measured through cognitive 
testing such as the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). 
Another secondary outcome was mood, measured by depression scores calculated from the Patient 
Health Questionnaire (PHQ-9). All participants filled out these questionnaires at the beginning and 
end of the program. 
The study found that HOBSCOTCH was effective in improving objective memory, particularly with 
regard to attention (3). This was demonstrated by a statistically significant increase in scores on the 
RBANS for those in the two intervention groups as compared to those in the control group. While 
there was an increase in quality of life for those in the intervention groups, it was not found to be 
statistically significant. Depression scores, as measured by the Patient Health Questionnaire (PHQ-9), 
did not change significantly for those in the intervention or control groups. No statistically significant 
difference was observed between the two intervention groups. Measuring Cost Effectiveness of HOBSCOTCH 
My research over the summer of 2015 involved evaluating the results of the 2013-2014 
HOBSCOTCH program in terms of its cost effectiveness. Karen Secore, APRN, was one of the 
clinicians researching HOBSCOTCH and became my mentor. Given the short, ten-week timeline and 
our resources, Karen and I chose to evaluate cost effectiveness by measuring healthcare utilization 
before and after HOBSCOTCH was implemented.  Our goal was to determine if a self-management 
program like HOBSCOTCH could be effective in decreasing healthcare costs in addition to helping 
patients meet specific health goals. 
Healthcare utilization data provides information on how often and which healthcare services patients 
utilize.  I conducted a literature review on how healthcare utilization data has been used to measure 
cost effectiveness. The simplest method is to compare the number of encounters with the healthcare 
system the patient has before and after an intervention (1).  This data can be further related to actual 
healthcare costs (6, 10, 11), and it can be combined with secondary measures, such as quality of life 
data, to further examine the effectiveness as well as cost of an intervention (12). I found that studies 
similar to ours had been usually conducted in the primary care setting (2). Some studies have 
additionally focused on patients with a higher than average number of encounters (8). This review 
validated the process we had chosen to use.  
I analyzed the medical records of the fifty-seven participants to determine healthcare utilization six 
months before and six months after 
participating in the program by counting 
the number of encounters during those 
periods.  These encounters included 
outpatient visits, telephone calls, 
emergency department visits, admissions, 
surgeries, and diagnostic tests. Outpatient 
visits and phone calls were divided into 
those specific to the neurology 
department and those with other 
departments to determine if the program 
affected neurology encounters more than 
others. 
For this study both intervention groups 
were combined as there was no 
significant difference in outcomes for 
these groups. In addition, eighteen 
patients who had five or more encounters 
in the six months prior to the program 
were categorized as high frequency 
patients. We wanted to look at this group 
separately to determine if HOBSCOTCH 
was more effective for these individuals 
than for others. 
I analyzed the data using SPSS statistics 
software version twenty-one. When 
looking at the combined intervention 
group, I found a decrease post-program in 
both total and neurology encounters, but 
the decrease was not statistically 
significant (p>0.05). However, there was 
a statistically significant decrease in the 
total number of encounters for those in the high frequency group (p = 0.001). (See Figures 1 and 2) 
I then took the depression and quality of life data from the first study and compared it to the data on 
neurology encounters. Before the program, high depression scores (meaning a deeper depression) 
 
Fig. 1: Comparing total encounters and neurology encounters 
for the high frequency group before and after HOBSCOTCH. 
Total Encounters: p=0.001* Neurology Encounters: p=0.886. 
*Statistical Significance, p<0.05 
 
Fig. 2: Comparing total encounters and neurology encounters 
before and after the HOBSCOTCH program. Total 
Encounters: p=0.246 Neurology Encounters: p=0.548  
were associated with a high number of neurology encounters. Low quality of life scores were also 
associated with a high number of encounters. This means that patients with depression and/or a 
decreased quality of life had more neurology encounters. 
After the patients completed HOBSCOTCH, high depression scores and low quality of life scores 
were not always associated with a high number of neurology encounters. In the control group high 
depression scores continued to be associated with a high number of neurology encounters although 
low quality of life scores were not.     What can this Mean? 
This study found that HOBSCOTCH lowers the number of healthcare encounters in those who utilize 
the healthcare system more than others, that is, the high frequency group. While these are positive 
results, they also highlight a bigger picture. The program aims to help patients manage a particular 
healthcare problem: memory impairment related to epilepsy. Improving a patient’s memory improves 
his/her quality of life and can also help decrease healthcare encounters. For example, memory 
impairment can contribute to not consistently taking medications. This can lead to an increased 
occurrence of seizures and poor control of other health conditions, which in turn lead to more 
healthcare encounters. After participating in HOBSCOTCH, the total number of encounters 
decreased in patients in the high frequency group. It is hypothesized that this decrease is the result of 
improved memory. 
As a part of the program, patients learn to recognize and manage memory impairment, which 
contributes to a decrease in the number of total healthcare encounters. This decrease results in a 
lowering of healthcare costs to both the patient and the healthcare system. 
The effect HOBSCOTCH has on healthcare utilization can also be seen in its effect on the association 
between depression, quality of life, and the number of neurology encounters. After participating in 
the program, low quality of life and/or high depression scores did not always result in a high number 
of neurology encounters. This suggests that the program empowers patients by giving them the tools 
to self-manage and cope with the cognitive changes associated with epilepsy. 
The small sample size is a limitation of this study. Fifty-seven and eighteen patients are relatively 
small sample sizes. A larger sample size would be needed to further generalize results. In addition, 
the increased number of encounters experienced by those in the high frequency group and the 
subsequent decrease could be random. 
Overall, these results make the case that self-management programs, both in epilepsy and in other 
chronic health conditions, can have a multitude of effects. This is particularly true for patients who 
utilize the healthcare system more than others. Rather than continuing to treat a problem solely with 
medication, providers can offer education and support, which can empower patients to better manage 
their conditions and decrease their number of healthcare encounters. 
Conducting this research helped me to grow as a nurse. It opened my eyes to the role nurses play in 
research, and to the extensive amount of work conducted behind the scenes of research studies. As I 
move forward in my nursing career, I plan to attend graduate school, which will involve conducting 
research. Before completing this internship, my skill set was primarily clinical. At this point, I know 
that my knowledge can be applied in a research setting, and that conducting research is very 
rewarding. I have gained a new sense of confidence in myself and an appreciation for research in 
nursing. In addition, I learned about what it takes to conduct research, and how you can learn a lot 
from negative results. 
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